Document Detail

Cardiogenic shock: can the prognosis be improved?
MedLine Citation:
PMID:  1105495     Owner:  NLM     Status:  MEDLINE    
The prognosis in cardiogenic shock remains poor despite improvements in treating other complications of acute myocardial infarction. In some situations, left ventricular function can be improved by increasing the vascular volume, but the benefits of increasing the cardiac uutput must be balanced agains the risk of pulmonary edema. Monitoring of volume therapy is best done via the pulmonary route. The goal of drug therapy is to raise arterial blood pressure and make the heart pump more effectively. An aggressive approach will not cure great numbers of extensive myocardial damage remains, but it will identify those who are hypovolemic or who have other correctable contributory factors. Most important, this approach may help to identify therapies currently in use that may actually increase rather than lessen myocardial damage.
R W Evans
Related Documents :
8722585 - Defibrillation shocks over epicardial patches produce sympathetic neural dysfunction in...
7245495 - Mechanical circulatory assistance for postoperative cardiogenic shock: a three year exp...
16597285 - Shock: a review of pathophysiology and management. part i.
1781765 - Phenomenon of the adaptive stabilization of sarcoplasmic and nuclear structures in myoc...
10694615 - Transmyocardial laser revascularization combined with coronary artery bypass grafting: ...
2720925 - Left ventricular contractility and function in kawasaki syndrome. effect of intravenous...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Postgraduate medicine     Volume:  58     ISSN:  0032-5481     ISO Abbreviation:  Postgrad Med     Publication Date:  1975 Dec 
Date Detail:
Created Date:  1976-02-09     Completed Date:  1976-02-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401147     Medline TA:  Postgrad Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  79-85     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure
Heart / physiopathology
Myocardial Infarction / complications
Pulmonary Artery / physiology
Pulmonary Edema / etiology
Shock, Cardiogenic / complications,  etiology,  mortality*,  physiopathology,  therapy
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Vasodilator Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of cytotoxic and immunosuppressive agents on the immune system.
Next Document:  The treatment of cerebral vascular disease.